"Designing Growth Strategies is in our DNA"

Cell and Gene Therapy Market Size, Share & Industry Analysis, By Type (By Cell Therapy {By Therapy Type [CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer Cells, &Others], By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, & Others], By Indication [Oncology & Others]}, and By Gene Therapy {By Vector Type [Viral Vectors & Non-Viral Vectors], By Product Type [Zolgensma, Luxturna, Roctavian, & Others], and By Indication [Genetic Diseases, Ophthalmology, Hematology, & Others]}), By End User (Hospitals & Clinics, Specialty Clinics, & Others), and Regional Forecast, 2026-2034

Last Updated: June 15, 2026 | Format: PDF | Report ID: FBI114130

 

Buy Now

(Offer valid till 15th Jul 2026)

  • 2021-2034
  • 2025
  • 2021-2024
  • 220
  • Buy Now

    (Offer valid till 15th Jul 2026)

Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann